| Entry |
|
|---|
| Name |
Envudeucitinib (USAN/INN) |
|---|
| Formula |
C22H24N6O3
|
|---|
| Exact mass |
426.2286
|
|---|
| Mol weight |
420.46
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Efficacy |
Anti-inflammatory, Tyrosine kinase 2 inhibitor |
|---|
| Comment |
Treatment of psoriasis and other immune-mediated inflammatory diseases
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04621 | NOD-like receptor signaling pathway |
| hsa04658 | Th1 and Th2 cell differentiation |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Non-receptor tyrosine kinases
JAK family
TYK2
D13123 Envudeucitinib (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 31
1 C8x C 10.5000 -14.9800
2 N5x N 10.5000 -16.3800
3 C8y C 11.6900 -17.0800
4 C8x C 12.8800 -16.3800
5 C8y C 12.8800 -14.9800
6 C8y C 11.6900 -14.2800
7 C5a C 11.6900 -12.8800
8 C1b C 10.5000 -12.1800
9 O5a O 12.8100 -12.1800
10 C1a C 9.3100 -12.8800
11 N1b N 11.6900 -18.4800
12 C5a C 10.5000 -19.1100
13 C1y C 9.3100 -18.4800
14 O5a O 10.5000 -20.5100
15 C1x C 8.6100 -17.2200
16 C1x C 7.8400 -18.4800
17 N1b N 14.1400 -14.2100
18 C8y C 15.4000 -14.9100
19 C8x C 15.4000 -16.3800
20 C8x C 16.5900 -17.0100
21 C8x C 17.8500 -16.3100
22 C8y C 17.8500 -14.9100
23 C8y C 16.5900 -14.2100
24 O2a O 16.5900 -12.8800
25 C8y C 19.0400 -14.2100
26 N5x N 19.4712 -12.8781
27 C8x C 20.8659 -12.8881
28 N4y N 21.3201 -14.2124
29 N5x N 20.1760 -15.0192
30 C1a C 22.6520 -14.6436
31 C1a C 17.8053 -12.1849
BOND 34
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 7 8 1
9 7 9 2
10 8 10 1
11 3 11 1
12 11 12 1
13 13 12 1
14 12 14 2
15 16 15 1
16 15 13 1
17 13 16 1
18 5 17 1
19 17 18 1
20 18 19 2
21 19 20 1
22 20 21 2
23 21 22 1
24 22 23 2
25 18 23 1
26 23 24 1
27 22 25 1
28 25 26 1
29 26 27 2
30 27 28 1
31 28 29 1
32 25 29 2
33 28 30 1
34 24 31 1
|
|---|
